NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
No results found when searching the local formulary, see alternative searches below.
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Abemaciclib Abemaciclib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Acalabrutinib Acalabrutinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Afatinib Afatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Aflibercept Aflibercept [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Aflibercept Aflibercept [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineovascularisation Drugs Vascular Endothelial Growth Factor Inhibitors
Alectinib  Alectinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Alpelisib Alpelisib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Asciminib Asciminib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Avapritinib Avapritinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Axitinib Axitinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Belzutifan Belzutifan [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Binimetinib  Binimetinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Bortezomib Bortezomib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Proteasome Inhibitors
Bosutinib Bosutinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Brigatinib Brigatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Cabozantinib Cabozantinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Capivasertib Capivasertib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Carfilzomib  Carfilzomib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Proteasome Inhibitors
Ceritinib Ceritinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Cobimetinib Cobimetinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Crizotinib Crizotinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Dabrafenib Dabrafenib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Dacomitinib Dacomitinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Dasatinib Dasatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Encorafenib  Encorafenib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Entrectinib Entrectinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Erdafitinib Erdafitinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Erlotinib Erlotinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Everolimus Everolimus Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Fedratinib Fedratinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Fruquintinib Fruquintinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Futibatinib Futibatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy
Gefitinib Gefitinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Gilteritinib Gilteritinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Glasdegib Glasdegib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Ibrutinib  Ibrutinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Idelalisib Idelalisib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Imatinib Imatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Ivosidenib Ivosidenib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Ixazomib Ixazomib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Proteasome Inhibitors
Lapatinib Lapatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Larotrectinib  Larotrectinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Lenvatinib Lenvatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Lorlatinib Lorlatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Midostaurin  Midostaurin [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Mobocertinib Mobocertinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Momelotinib Momelotinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Neratinib Neratinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Nilotinib Nilotinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Nintedanib Nintedanib Malignant Disease, Targeted Therapy Responsive Malignancy
Nintedanib Nintedanib Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Niraparib  Niraparib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Olaparib Olaparib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Osimertinib  Osimertinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Palbociclib  Palbociclib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Pazopanib Pazopanib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Pemigatinib Pemigatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Ponatinib  Ponatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Pralsetinib Pralsetinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Quizartinib Quizartinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Regorafenib  Regorafenib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Ribociclib  Ribociclib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Ripretinib Ripretinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Rucaparib Rucaparib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Ruxolitinib Ruxolitinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Selinexor Selinexor [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Selpercatinib Selpercatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Sorafenib  Sorafenib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Sotorasib Sotorasib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Sunitinib Sunitinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Talazoparib  Talazoparib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Tebentafusp Tebentafusp [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Temsirolimus Temsirolimus [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Tepotinib Tepotinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Tivozanib  Tivozanib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Trametinib Trametinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Tucatinib Tucatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Vandetanib Vandetanib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Vemurafenib Vemurafenib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Venetoclax  Venetoclax [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Vismodegib  Vismodegib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Antineoplastics, Other
Zanubrutinib Zanubrutinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
No exact matches found - Possible matches - use with care.
Status Description Section
REDTrastuzumab Herceptin® Malignant disease and immunosuppression, Trastuzumab, 08.01.05
REDTrastuzumab deruxtecan Enhertu® Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05 100 mg powder for concentrate for solution for infusion
REDTrastuzumab emtansine Kadcyla® Malignant disease and immunosuppression, Trastuzumab, 08.01.05
Amber SPATrazodone  Central nervous system, Related antidepressants, 04.03.01
 Trisodium Citrate 46.7%  Unlicensed Medicines / Significant off-label use, Unlicensed Medicines, 20